Literature DB >> 22634617

IL-2 requirement for human plasma cell generation: coupling differentiation and proliferation by enhancing MAPK-ERK signaling.

Simon Le Gallou1, Gersende Caron, Céline Delaloy, Delphine Rossille, Karin Tarte, Thierry Fest.   

Abstract

Mature B cell differentiation involves a well-established transcription factor cascade. However, the temporal dynamics of cell signaling pathways regulating transcription factor network and coordinating cell proliferation and differentiation remain poorly defined. To gain insight into the molecular processes and extrinsic cues required for B cell differentiation, we set up a controlled primary culture system to differentiate human naive B cells into plasma cells (PCs). We identified T cell-produced IL-2 to be critically involved in ERK1/2-triggered PC differentiation. IL-2 drove activated B cell differentiation toward PC independently of its proliferation and survival functions. Indeed, IL-2 potentiated ERK activation and subsequent BACH2 and IRF8 downregulation, sustaining BLIMP1 expression, the master regulator for PC differentiation. Inhibition of the MAPK-ERK pathway, unlike STAT5 signaling, impaired IL-2-induced PC differentiation and rescued the expression profile of BACH2 and IRF8. These results identify IL-2 as a crucial early input in mature B cell fate commitment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634617     DOI: 10.4049/jimmunol.1200301

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant.

Authors:  Olivier Thaunat; Alice Koenig; Claire Leibler; Philippe Grimbert
Journal:  J Am Soc Nephrol       Date:  2016-02-12       Impact factor: 10.121

2.  IL-2, IL-4, IFN-γ or TNF-α enhances BAFF-stimulated cell viability and survival by activating Erk1/2 and S6K1 pathways in neoplastic B-lymphoid cells.

Authors:  Lin Gui; Qingyu Zeng; Zhigang Xu; Hai Zhang; Shanshan Qin; Chunxiao Liu; Chong Xu; Zhou Qian; Shuangquan Zhang; Shile Huang; Long Chen
Journal:  Cytokine       Date:  2016-05-25       Impact factor: 3.861

3.  Increased CD40 Ligation and Reduced BCR Signalling Leads to Higher IL-10 Production in B Cells From Tolerant Kidney Transplant Patients.

Authors:  Estefania Nova-Lamperti; Prabhjoat Chana; Paula Mobillo; Manohursingh Runglall; Yogesh Kamra; Reuben McGregor; Graham M Lord; Robert I Lechler; Giovanna Lombardi; Maria P Hernandez-Fuentes
Journal:  Transplantation       Date:  2017-03       Impact factor: 4.939

4.  IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts.

Authors:  Lucinda J Berglund; Danielle T Avery; Cindy S Ma; Leen Moens; Elissa K Deenick; Jacinta Bustamante; Stephanie Boisson-Dupuis; Melanie Wong; Stephen Adelstein; Peter D Arkwright; Rosa Bacchetta; Liliana Bezrodnik; Harjit Dadi; Chaim M Roifman; David A Fulcher; John B Ziegler; Joanne M Smart; Masao Kobayashi; Capucine Picard; Anne Durandy; Matthew C Cook; Jean-Laurent Casanova; Gulbu Uzel; Stuart G Tangye
Journal:  Blood       Date:  2013-10-24       Impact factor: 22.113

5.  Expression of CD117 (c-Kit) on Circulating B Cells in Pediatric Schistosomiasis.

Authors:  Isaac O Onkanga; Rachael Hamilton; Pauline N M Mwinzi; Thomas Schneider; Bartholomew N Ondigo; Huldah Sang; Edna Ondari; Fredrick Rawago; Walter Jaoko; Maurice R Odiere; Lisa Ganley-Leal
Journal:  Infect Immun       Date:  2022-07-06       Impact factor: 3.609

6.  Modulation of the IL-6 Receptor α Underlies GLI2-Mediated Regulation of Ig Secretion in Waldenström Macroglobulinemia Cells.

Authors:  David A Jackson; Timothy D Smith; Nansalmaa Amarsaikhan; Weiguo Han; Matthew S Neil; Shannon K Boi; Anne M Vrabel; Ezequiel J Tolosa; Luciana L Almada; Martin E Fernandez-Zapico; Sherine F Elsawa
Journal:  J Immunol       Date:  2015-08-03       Impact factor: 5.422

7.  FunRes: resolving tissue-specific functional cell states based on a cell-cell communication network model.

Authors:  Sascha Jung; Kartikeya Singh; Antonio Del Sol
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

Review 8.  The Potential of Harnessing IL-2-Mediated Immunosuppression to Prevent Pathogenic B Cell Responses.

Authors:  Amber Papillion; André Ballesteros-Tato
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

Review 9.  Low-Dose IL-2 in the Treatment of Lupus.

Authors:  Masayuki Mizui; George C Tsokos
Journal:  Curr Rheumatol Rep       Date:  2016-11       Impact factor: 4.686

Review 10.  Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells.

Authors:  Yoshiko Matsuda; Takeshi Watanabe; Xiao-Kang Li
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.